ACUT — ACCUSTEM SCIENCES Balance Sheet
0.000.00%
- $24.91m
- $24.95m
- 15
- 37
- 52
- 25
Annual balance sheet for ACCUSTEM SCIENCES, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
| 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Cash and Short Term Investments | — | — | 0.734 | 0.021 | 0.005 | 
| Net Total Receivables | 1.37 | 1.35 | 0 | — | — | 
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.37 | 1.35 | 0.932 | 0.13 | 0.05 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | — | 0.008 | 0.004 | 0 | 
| Total Assets | 1.37 | 1.35 | 0.94 | 0.134 | 0.051 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.055 | 0.703 | 1.08 | 2.25 | 3.36 | 
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.055 | 0.703 | 1.08 | 2.25 | 3.36 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1.31 | 0.651 | -0.14 | -2.11 | -3.31 | 
| Total Liabilities & Shareholders' Equity | 1.37 | 1.35 | 0.94 | 0.134 | 0.051 | 
| Total Common Shares Outstanding |